Actinium Pharmaceuticals Company
Actinium Pharmaceuticals develops alpha particle linked antibodies to treat cancer.
Industry:
Healthcare Solutions
Headquarters:
New York, New York, United States
Founded Date:
2000-01-01
Funding Status:
IPO
Total Funding:
106125720
Estimated Revenue:
Less than $1M
Last Funding Date:
2020-06-16
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership